OBALON THERPTCS (OBLN)
(Delayed Data from NSDQ)
$0.43 USD
-0.01 (-3.15%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.43 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.43 USD
-0.01 (-3.15%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.43 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Is OBALON THERPTCS (OBLN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (OBLN) Outperforming Other Medical Stocks This Year?
OBALON THERPTCS (OBLN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of 82.57% and -84.86%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
OBALON THERPTCS (OBLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will OBALON THERPTCS (OBLN) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OBALON THERPTCS (OBLN) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of 7.41% and -78.79%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Hottest Wall Street Stories: What's Up, What's Down
by Sweta Killa
Tariff tantrums hit the broader stock markets last month, leading to the worst May after 2010. Below we discuss these in detail and the impact on the stock world from these events.
OBALON THERPTCS (OBLN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, OBALON THERPTCS (OBLN) closed at $0.68, marking a -0.37% move from the previous day.
OBALON THERPTCS (OBLN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
OBALON THERPTCS (OBLN) closed the most recent trading day at $0.42, moving -1.96% from the previous trading session.
Will OBALON THERPTCS (OBLN) Report Negative Q1 Earnings? What You Should Know
by Zacks Equity Research
OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OBALON THERPTCS (OBLN) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of -25.81% and -3.05%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Battered Stocks That Could Be Big Winners in 2019
by Zacks Equity Research
Here we pick five stocks that have plunged more than 30% in 2018 but have promising fundamentals.
OBALON THERPTCS (OBLN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of 23.91% and 21.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Obalon's (OBLN) Q3 Earnings Reflect Growth in U.S.?
by Zacks Equity Research
Obalon (OBLN) is expected to register robust U.S. revenues in Q3, backed by higher reorders from existing accounts and new order bookings.
OBALON THERPTCS (OBLN) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.